Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced it has signed a national purchasing agreement with Amerinet for the Fresenius Kabi Agilia large volume infusion pump and related disposables.
Amerinet is a group purchasing organization with more than 80,000 members, including hospitals, surgery centers, clinics, and other sites of care.
"We’re pleased to secure this significant GPO contract for our first smart infusion pump available in the United States," said John Ducker, president and CEO of Fresenius Kabi USA.
"This is an important step for Fresenius Kabi as we look to bring other infusion technologies to U.S. caregivers and patients."
The Agilia pump was launched in the US in late 2014 and has been in use in 99 countries since 2007.
The Agilia large volume pump with Vigilant drug safety software is a lightweight pump (4.4 pounds) with a range of features and functionality to assist health care providers in the safe administration of infusion therapy.
Fresenius Kabi is a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition.